Related Experiment Video
Updated: Jun 22, 2026
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
[Modern therapy concepts for endometrial cancer]
G Emons1, M Hellriegel, T Hawighorst
1Klinik für Gynäkologie und Geburtshilfe, Georg-August-Universität Göttingen, Göttingen, Deutschland. emons@med.uni-goettingen.de
Der Pathologe
|June 5, 2009
Summary
Endometrial cancer (EC) treatment varies by stage and grade. While surgery is adequate for early stages, advanced EC requires further evaluation of lymphadenectomy, radiotherapy, and chemotherapy effectiveness.
Area of Science:
- Gynecologic Oncology
- Cancer Therapeutics
- Clinical Trial Design
Context:
- Endometrial cancer (EC) is often diagnosed early, but advanced stages and certain subtypes (Type II EC) require more aggressive treatment.
- Traditional treatment involves hysterectomy and salpingo-oophorectomy, which may be insufficient for high-risk cases.
Purpose:
- To evaluate the efficacy of various treatment modalities for endometrial cancer beyond traditional surgery.
- To determine the role of lymphadenectomy, radiotherapy, and chemotherapy in improving outcomes for high-risk EC patients.
Summary:
- Early-stage, low-grade EC (endometrioid, pT1a, pT1b; G1, G2) is adequately treated with hysterectomy and salpingo-oophorectomy.
- High-risk EC necessitates further investigation into systematic pelvic and paraaortic lymphadenectomy.
- External pelvic radiotherapy improves local control but not survival; vaginal brachytherapy offers similar local control with less toxicity.
- Adjuvant chemotherapy shows probable efficacy, but its optimal use in combination with other therapies requires prospective trials.
Impact:
- Highlights the limitations of standard treatment for advanced endometrial cancer.
- Identifies key areas for future research, including the role of lymphadenectomy and adjuvant therapies.
- Suggests vaginal brachytherapy as a less toxic alternative to external beam radiotherapy for local control.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...